EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Monocytes Reprogrammed by 4-PBA Potently Contribute to the Resolution of Inflammation and Atherosclerosis

Shuo Geng iD, Ran Lu, Yao Zhang iD, Yajun Wu iD, Ling Xie, Blake A Caldwell iD, Kisha Pradhan, Ziyue Yi iD, Jacqueline Hou, Feng Xu, Xian Chen, Liwu Li iD

Circulation Research · 27.09.2024 · 135 (8) · 856-872

DOI: 10.1161/circresaha.124.325023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, erschienen am 27.09.2024. Verfasst von Shuo Geng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Virginia Tech, Blacksburg (S.G., R.L., Y.Z., Y.W., B.A.C., K.P., Z.Y., J.H., F.X., L.L.). Hauptthemen laut MEDLINE: Atherosclerosis, Monocytes, Inflammation, Phenylbutyrates. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chronic inflammation initiated by inflammatory monocytes underlies the pathogenesis of atherosclerosis. However, approaches that can effectively resolve chronic low-grade inflammation targeting monocytes are not readily available. The small chemical compound 4-phenylbutyric acid (4-PBA) exhibits broad anti-inflammatory effects in reducing atherosclerosis. Selective delivery of 4-PBA reprogrammed monocytes may hold novel potential in providing targeted and precision therapeutics for the treatment of atherosclerosis. METHODS: Systems analyses integrating single-cell RNA sequencing and complementary immunologic approaches characterized key resolving characteristics as well as defining markers of reprogrammed monocytes trained by 4-PBA. Molecular mechanisms responsible for monocyte reprogramming were assessed by integrated biochemical and genetic approaches. The intercellular propagation of homeostasis resolution was evaluated by coculture assays with donor monocytes trained by 4-PBA and recipient naive monocytes. The in vivo effects of monocyte resolution and atherosclerosis prevention by 4-PBA were assessed with the high-fat diet-fed ApoE −/− mouse model with IP 4-PBA administration. Furthermore, the selective efficacy of 4-PBA-trained monocytes was examined by IV transfusion of ex vivo trained monocytes by 4-PBA into recipient high-fat diet-fed ApoE −/− mice. RESULTS: In this study, we found that monocytes can be potently reprogrammed by 4-PBA into an immune-resolving state characterized by reduced adhesion and enhanced expression of anti-inflammatory mediator CD24. Mechanistically, 4-PBA reduced the expression of ICAM-1 (intercellular adhesion molecule 1) via reducing peroxisome stress and attenuating SYK (spleen tyrosine kinase)-mTOR (mammalian target of rapamycin) signaling. Concurrently, 4-PBA enhanced the expression of resolving mediator CD24 through promoting PPARγ (peroxisome proliferator-activated receptor γ) neddylation mediated by TOLLIP (toll-interacting protein). 4-PBA-trained monocytes can effectively propagate anti-inflammation activity to neighboring monocytes through CD24. Our data further demonstrated that 4-PBA-trained monocytes effectively reduce atherosclerosis pathogenesis when administered in vivo. CONCLUSIONS: Our study describes a robust and effective approach to generate resolving monocytes, characterizes novel mechanisms for targeted monocyte reprogramming, and offers a precision therapeutics for atherosclerosis based on delivering reprogrammed resolving monocytes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisMonocytesInflammationPhenylbutyratesAnimalsMiceMice, Inbred C57BLHumansMaleIntercellular Adhesion Molecule-1Mice, Knockout, ApoEPPAR gammaCellular ReprogrammingCells, CulturedAnti-Inflammatory Agents

Stichwörter der Autor:innen

atherosclerosisimmunity, innateinflammationmonocytestherapeutics

Substanzen

4-phenylbutyric acidPhenylbutyratesIntercellular Adhesion Molecule-1PPAR gammaAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Biological Sciences, Virginia Tech, Blacksburg (S.G., R.L., Y.Z., Y.W., B.A.C., K.P., Z.Y., J.H., F.X., L.L.).
  • Department of Biochemistry and Molecular Biology, University of North Carolina at Chappell Hill, NC (L.X., X.C.).

ORCID-Profile: Shuo Geng, Yao Zhang, Yajun Wu, Blake A Caldwell, Ziyue Yi, Liwu Li

Förderung

  • NHLBI NIH HHS
  • NIA NIH HHS
  • NIDDK NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Geng, S., Lu, R., Zhang, Y., Wu, Y., Xie, L., Caldwell, B. A., Pradhan, K., Yi, Z., Hou, J., Xu, F., Chen, X., & Li, L. (2024). Monocytes Reprogrammed by 4-PBA Potently Contribute to the Resolution of Inflammation and Atherosclerosis. Circulation Research, 135(8), 856-872. https://doi.org/10.1161/circresaha.124.325023

Vancouver

Geng S, Lu R, Zhang Y, Wu Y, Xie L, Caldwell BA, et al. Monocytes Reprogrammed by 4-PBA Potently Contribute to the Resolution of Inflammation and Atherosclerosis. Circulation Research. 2024;135(8):856-872. doi:10.1161/circresaha.124.325023

BibTeX
@article{Geng2024,
  author = {Geng, Shuo and Lu, Ran and Zhang, Yao and Wu, Yajun and Xie, Ling and Caldwell, Blake A and Pradhan, Kisha and Yi, Ziyue and Hou, Jacqueline and Xu, Feng and Chen, Xian and Li, Liwu},
  title = {Monocytes Reprogrammed by 4-PBA Potently Contribute to the Resolution of Inflammation and Atherosclerosis},
  journal = {Circulation Research},
  year = {2024},
  volume = {135},
  number = {8},
  pages = {856--872},
  doi = {10.1161/circresaha.124.325023}
}
Kostenlos starten →